Scholarly Index
Elise C. Kohn
National Cancer Institute; 27,717 total citations; 405 total publications; best world rank #65
National Cancer Institute
27,717Total citations
405Total publications
79H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Ovarian cancer diagnosis and treatment | Lifetime | 126 | US 73 | 99.34 |
| PARP inhibition in cancer therapy | Lifetime | 65 | US 35 | 98.93 |
| Advanced Biosensing Techniques and Applications | Lifetime | 110 | US 41 | 97.92 |
| Angiogenesis and VEGF in Cancer | Lifetime | 362 | US 166 | 97.75 |
| Protease and Inhibitor Mechanisms | Lifetime | 386 | US 171 | 97.56 |
| Cancer Treatment and Pharmacology | Lifetime | 732 | US 359 | 98.07 |
| Advanced Proteomics Techniques and Applications | Lifetime | 264 | US 125 | 97.20 |
| Peptidase Inhibition and Analysis | Lifetime | 928 | US 408 | 97.16 |
| Cell Adhesion Molecules Research | Lifetime | 905 | US 444 | 97.47 |
| BRCA gene mutations in cancer | Lifetime | 816 | US 416 | 95.32 |
| PARP inhibition in cancer therapy | 2021-2025 | 741 | US 273 | 81.94 |
| Chromatin Remodeling and Cancer | 2021-2025 | 999 | US 388 | 52.75 |